MediFind

Find a Doctor

Deepti Behl

Sutter Valley Medical Foundation
Hematology, Oncology, Internal Medicine
Female
Practicing approx. 21 years

Bio


Deepti Behl is a Hematologist and an Oncologist in Sacramento, California. She has been an author on 8 peer reviewed articles and participated in 102 clinical trials in the past 15 years. Dr. Behl's top three areas of expertise are Lung Cancer, Pancreatic Cancer, and Non-Small Cell Lung Cancer. She is licensed to treat patients in CA and MN.

Contact

2800 L St
Sacramento, CA 95816, US

Latest Research


Latest Advance
Study
  • Condition: Metastatic Pancreatic Adenocarcinoma
  • Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Treatment Used: FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone
  • Number of Patients: 138
  • Published —
In this study, researchers compared the effectiveness of the FOLFIRINOX chemotherapy regimen plus pegylated recombinant human hyaluronidase versus FOLFIRINOX alone for the treatment of metastatic pancreatic cancer.

Clinical Trials


Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 480
  • Start Date: March 25, 2020
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 506
  • Start Date: May 28, 2019
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Clinical Trial
Procedure
  • Status: Recruiting
  • Study Type: Procedure
  • Participants: 500
  • Start Date: December 6, 2018
A Phase II Randomized Study of Adjuvant Versus NeoAdjuvant Pembrolizumab (MK-3475) for Clinically Detectable Stage III-IV High-Risk Melanoma

All Publications
View All


Publication
Study
  • Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Published —
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313.
Publication
Study
  • Journal: Journal of palliative medicine
  • Published —
What do oncologists say about chemotherapy at the very end of life? Results from a semiqualitative survey.

Contact

2800 L St
Sacramento, CA 95816, US

Affiliations

  • Sutter Medical Center, Sacramento
  • Sutter Amador Hospital
  • Sutter Roseville Medical Center
  • Sutter Auburn Faith Hospital
  • Sutter Davis Hospital

Credentials

  • Licenses
    Internal Medicine in CA
  • Board Certifications
    Hematology/oncology

Insurance

Contact them to find out if they accept your insurance plan.